Medicare beneficiaries would gain more pharmacy choice and transparency on drug costs.
This bill would give Medicare beneficiaries more choices for where they get their prescriptions filled. It would also make Pharmacy Benefit Managers (PBMs) more transparent about how they handle drug costs and rebates. This aims to ensure PBMs act in the best interest of Medicare plans and patients. These changes would generally take effect starting in 2028.
Currently, Medicare drug plans can limit which pharmacies are in their networks, and Pharmacy Benefit Managers (PBMs) operate with less transparency regarding their earnings and how they handle drug rebates. After this bill, Medicare drug plans would have to accept any willing pharmacy that meets fair contract terms, and PBMs would be restricted to "bona fide service fees" and required to pass rebates to plans. PBMs would also have to provide detailed financial reports, increasing transparency and accountability in the drug supply chain.
S 882 · 119th Congress · AI Summary by gemini-2.5-flash · 8/10
Sign in to see your representatives' phone numbers
25 filings mentioned this bill
Amounts reflect total quarterly lobbying spend reported to the Senate, not bill-specific spending. Source: Senate LDA filings.